Fig. 5From: In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibitionHER2-overexpressing BC (HER2). a Pathway network: nodes represent pathways (100) and edges represent interactions between pathways (222); b Boxplot of AUC values for training and testing dataset; c Trend of new network efficiency (nNE) calculated after removal of individual pathways; d nNE values calculated after removal of all combinations of couples of pathways. Red lines represent the efficiency of the original network (NE)Back to article page